This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
TransEnterix's MST Medical Buyout to Boost Senhance Platform
by Zacks Equity Research
TransEnterix (TRXC) acquires Israel-based MST Medical, which will boost surgeons' effectiveness and make procedures quick and error-free.
Here's Why You Should Buy Intuitive Surgical (ISRG) Now
by Zacks Equity Research
Strength in the surgical platform and a string of developments make Intuitive Surgical (ISRG) a promising pick.
Cerner's CommunityWorks Picked by Reeves County Hospital
by Zacks Equity Research
Cerner (CERN) sees a slew of developments in its EHR platform, market prospects bright.
Here's Why You Should Hold Becton, Dickinson (BDX) Stock Now
by Zacks Equity Research
Becton, Dickinson (BD) is likely to gain from expansion into emerging overseas markets.
Abbott Banks on New Approvals and Buyouts, Competition Rife
by Zacks Equity Research
Abbott's (ABT) receipt of FDA approval for XIENCE Sierra coronary stent system as well as a reimbursement approval in Japan for the same device will help it revive the dull Vascular business.
3 Top Stocks From the Booming US Medical Products Industry
by Sreyoshi Mukherjee
The U.S. Medical Products industry is sturdy on solid focus on technological advancement.
Cerner Integrated Platform Implemented by Spectrum Health
by Zacks Equity Research
Spectrum Health selects Cerner's (CERN) Cerner Integrated Platform to treat psychological disorders.
athenahealth Enters Oversold Territory
by Zacks Equity Research
athenahealth has been on a bit of a cold streak lately.
Here's Why You Should Hold AngioDynamics' (ANGO) Stock Now
by Zacks Equity Research
AngioDynamics (ANGO) to benefit from a solid product portfolio. However, the company???s core Peripheral Vascular business has been sluggish.
Veeva's Vault CDMS to Unify Clinical Data in Single Platform
by Zacks Equity Research
Veeva's (VEEV) cloud-based applications' market prospects bright.
Here's Why You Should Invest in Masimo (MASI) Right Now
by Zacks Equity Research
A raised guidance for 2018 and positive developments make Masimo (MASI) a lucrative choice for investors.
Cooper's MiSight Lens Effective in Checking Juvenile Myopia
by Zacks Equity Research
Cooper's (COO) core CVI business gets a boost from MiSight's positive study results.
Why athenahealth (ATHN) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
athenahealth (ATHN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
DaVita Kidney Care Opens 150000-Square-Foot Campus in DeLand
by Zacks Equity Research
DaVita's (DVA) dialysis care in the United States gets a boost; market prospects solid.
Cyber Attack Fears Grip MedTech: 3 Safe Stocks
by Sweta Jaiswal
In the wake of rising incidences of cyber attacks in the MedTech space, we have zeroed down on some stocks which at present are safe-havens for investors.
Veeva Gains as MD&D Companies Pick Its Cloud-Based Services
by Zacks Equity Research
Veeva's (VEEV) focus on cloud-based services is likely to open up substantial opportunities for the company.
Stryker (SYK) to Acquire Invuity, Boost Surgical Portfolio
by Zacks Equity Research
Stryker (SYK) on an acquisition spree; latest buyout likely to aid its array of surgical instruments.
Varian Up on Tie-Up With Kenya's Mediheal Group of Hospitals
by Zacks Equity Research
Varian's (VAR) advanced cancer care solution prospects bright in the global market.
3 Cloud-Powered MedTech Stocks to Buy Right Now
by Nabaparna Bhattacharya
Here we take a look at three MedTech companies that are likely to make big business banking on cloud technologies.
Here's Why You Should Invest in Surmodics (SRDX) Stock Now
by Zacks Equity Research
Continuous focus on R&D and a raised guidance for fiscal 2018 make Surmodics (SRDX) a lucrative pick for investors.
Zacks.com highlights: athenahealth, Medifast, Commvault Systems, Molina Healthcare and Fortinet
by Zacks Equity Research
Zacks.com highlights: athenahealth, Medifast, Commvault Systems, Molina Healthcare and Fortinet
The Zacks Analyst Blog Highlights: Caterpillar, D.R. Horton, Bristol-Myers Squibb, athenahealth and BJ's Restaurants
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Caterpillar, D.R. Horton, Bristol-Myers Squibb, athenahealth and BJ's Restaurants
Bet on These 5 Top Liquid Stocks for Stellar Returns
by Zacks Equity Research
Five top-ranked liquid stocks that are poised to offer marvelous returns.
September Bogging You? Look at the Best 9-Month Run Instead
by Tirthankar Chakraborty
During midterm election years, Q4 delivers a 6.7% jump on average for the S&P 500, while the index registers gains of 5.2% and 4.5% for the next year's Q1 and Q2, respectively.
Here's Why You Should Invest in athenahealth (ATHN) Now
by Zacks Equity Research
Focus on cloud-based services and a lifted guidance for 2018 make athenahealth (ATHN) an attractive pick.